Resultats globals: 32 registres trobats en 0.03 segons.
Articles, 32 registres trobats
Articles 32 registres trobats  1 - 10següentfinal  anar al registre:
1.
10 p, 988.4 KB Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly / van der Lely, Aart J. (Erasmus University Medical Center) ; Gomez, Roy (Pfizer Medical Affairs) ; Pleil, Andreas (Pfizer Inc) ; Badia, Xavier (University of Barcelona and Omakase Consulting) ; Brue, Thierry (Centre de Référence des Maladies Rares de l'hypophyse HYPO) ; Buchfelder, Michael (Universitatsklinikum Erlangen) ; Burman, Pia (University of Lund) ; Clemmons, David (UNC Hospitals Diabetes and Endocrinology Clinic) ; Ghigo, Ezio (University Hospital Città Salute e Scienza) ; Jorgensen, Jens Otto Lunde (Aarhus University) ; Luger, Anton (Medizinische Universität und Allgemeines Krankenhaus Wien) ; van der Lans-Bussemaker, Joli (Pfizer Medical Affairs) ; Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ; Strasburger, Christian J. (Charitė Universitätsmedizin Berlin) ; Universitat Autònoma de Barcelona
Despite availability of multimodal treatment options for acromegaly, achievement of long-term disease control is suboptimal in a significant number of patients. Furthermore, disease control as defined by biochemical normalization may not always show concordance with disease-related symptoms or patient's perceived quality of life. [...]
2017 - 10.1007/s11102-017-0835-5
Pituitary, Vol. 20 Núm. 6 (january 2017) , p. 692-701  
2.
11 p, 1.8 MB Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study / Podzamczer, D. (Hospital Universitari de Bellvitge) ; Rozas, N. (Hospital Universitari de Bellvitge) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Miralles, C. (Hospital Xeral de Vigo) ; Van den Eynde, E. (Hospital Universitari de Bellvitge) ; Romero, A. (Hospital de Especialidades de Puerto Real) ; Deig, E. (Hospital General de Granollers) ; Knobel Freud, Hernando (Hospital del Mar (Barcelona, Catalunya)) ; Pasquau, J. (Hospital Universitario Virgen de las Nieves (Granada)) ; Antela, A. (Complejo Hospitalario Universitario de Santiago de Compostela) ; Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Geijo, P. (Hospital Virgen de La Luz (Cuenca)) ; Rodríguez de Castro, E. (Hospital Mateu Orfila) ; Casado, M.A. (Pharmacoeconomics & Outcomes Research Iberia) ; Muñoz, A. (Pharmacoeconomics & Outcomes Research Iberia) ; Casado, A. (Pharmacoeconomics & Outcomes Research Iberia) ; Universitat Autònoma de Barcelona
To investigate the impact of switching from stable Combined Antiretroviral Therapy (cART) to single-tablet regimen (RPV/FTC/TDF=EVIPLERA®/COMPLERA®) on patient-reported outcomes in HIV-infected adults who cannot tolerate previous cART, in a real-world setting. [...]
2018 - 10.2174/1570162X17666190212163518
Current HIV Research, Vol. 16 Núm. 6 (2018) , p. 425-435  
3.
13 p, 266.5 KB Poorer quality of life and treatment satisfaction is associated with diabetic retinopathy in patients with type 1 diabetes without other advanced late complications / Granado-Casas, Minerva (Institut d'Investigació Biomèdica Sant Pau) ; Castelblanco, Esmeralda (Institut d'Investigació Biomèdica Sant Pau) ; Ramírez-Morros, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martín, Mariona (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Alcubierre, Nuria (Universitat de Lleida) ; Martínez-Alonso, M. (Institut de Recerca Biomèdica de Lleida) ; Valldeperas, Xavier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Traveset, A. (Hospital Universitari Arnau de Vilanova) ; Rubinat, Esther (Universitat de Lleida) ; Lucas-Martin, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernández, Marta (Hospital Universitari Arnau de Vilanova) ; Alonso Pedrol, Núria (Instituto de Salud Carlos III) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Diabetic retinopathy (DR) may potentially cause vision loss and affect the patient's quality of life (QoL) and treatment satisfaction (TS). Using specific tools, we aimed to assess the impact of DR and clinical factors on the QoL and TS in patients with type 1 diabetes. [...]
2019 - 10.3390/jcm8030377
Journal of clinical medicine, Vol. 8 Núm. 3 (march 2019) , p. 377  
4.
7 p, 769.8 KB An analysis of patient-reported outcomes in ixora-s : Comparing ixekizumab and ustekinumab over 52 weeks in moderate-to-severe psoriasis / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Lomaga, M. (DermEdge Research and Probity Medical Research) ; Hollister, K. (Eli Lilly and Company) ; Dutronc, Y. (Eli Lilly and Company) ; Berggren, L. (HaaPACS GmbH) ; Van De Kerkhof, P. (Radboud University Nijmegen Medical Centre) ; Universitat Autònoma de Barcelona
Patient-reported outcomes are valuable for assessing new psoriasis therapies. This study investigated patient-reported outcomes in patients with moderate-to-severe plaque psoriasis treated with ixekizumab or ustekinumab, dosed according to their respective labels, for 52 weeks (IXORA-S-NCT02561806). [...]
2020 - 10.2340/00015555-3700
Acta dermato-venereologica, Vol. 100 Núm. 19 (2020) , p. 1-7  
5.
16 p, 329.8 KB Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective : An Observational Cross-Sectional Study / Meca-Lallana, José E. (Hospital Universitario Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca. Unidad de Neuroinmunología Clínica y Esclerosis Múltiple CSUR. Servicio de Neurología) ; Gómez-Ballesteros, Rocío (Medical Department. Roche Farma) ; Pérez-Miralles, Francisco (Hospital Universitari i Politècnic La Fe. Unidad de Neuroinmunología. Servicio de Neurología) ; Forero, Lucía (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ; Sepúlveda, María (Hospital Clínic i Provincial de Barcelona) ; Calles, Carmen (Hospital Universitario Son Espases. Servicio de Neurología) ; Martínez-Ginés, María L. (Hospital General Universitario Gregorio Marañón) ; González-Suárez, Inés (Hospital Universitario Álvaro Cunqueiro. Servicio de Neurología) ; Boyero, Sabas (Hospital de Cruces (Barakaldo). Servicio de Neurología) ; Romero-Pinel, Lucía (Hospital Universitari de Bellvitge) ; Sempere, Ángel P. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Meca-Lallana, V. (Department of Neurology. Hospital Universitario La Princesa) ; Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ; Prefasi, Daniel (Medical Department. Roche Farma) ; Maurino, Jorge (Medical Department. Roche Farma)
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is associated with a reduced health-related quality of life (HRQoL). The purpose of this study was to describe the impact of NMOSD on HRQoL from the patients' perspective and its relationship with other disease factors. [...]
2022 - 10.1007/s40120-022-00356-6
Neurology and Therapy, Vol. 11 Núm. 3 (september 2022) , p. 1101-1116  
6.
10 p, 1.5 MB Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis : analysis of pooled data from the randomized trials SOLO 1 and SOLO 2 / Cork, M.J. (University of Sheffield Medical School) ; Eckert, L. (Sanofi) ; Simpson, E.L. (Oregon Health & Science University) ; Armstrong, A. (Keck School of Medicine at USC. University of Southern California) ; Barbarot, Sebastien (CHU Hôtel-Dieu) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Girolomoni, G. (University of Verona) ; de Bruin-Weller, Marjolein (University Medical Center Utrecht) ; Wollenberg, A. (Klinikum der Universität München) ; Kataoka, Y. (Osaka Habikino Medical Center) ; Remitz, A. (Helsinki University Central Hospital) ; Beissert, Stefan (Technische Universität Dresden) ; Mastey, V. (Regeneron Pharmaceuticals Inc.) ; Ardeleanu, Marius (Regeneron Pharmaceuticals Inc.) ; Chen, Z. (Regeneron Pharmaceuticals Inc.) ; Gadkari, A. (Regeneron Pharmaceuticals Inc.) ; Chao, J. (Regeneron Pharmaceuticals Inc.) ; Universitat Autònoma de Barcelona
Atopic dermatitis (AD) profoundly affects quality of life (QoL). Dupilumab significantly improves clinical outcomes, is well tolerated, and approved to treat inadequately controlled moderate-to-severe AD in adults; however, its effect on patient-reported outcomes (PROs) is not fully characterized. [...]
2020 - 10.1080/09546634.2019.1612836
Journal of Dermatological Treatment, Vol. 31 Núm. 6 (17 2020) , p. 606-614  
7.
14 p, 1.1 MB The Intestinal Gas Questionnaire (IGQ) : Psychometric validation of a new instrument for measuring gas-related symptoms and their impact on daily life among general population and irritable bowel syndrome / Duracinsky, Martin (AP-HP) ; Archbold, Sharon (University of Manchester) ; Lobo Álvarez, Beatriz (Hospital Universitari Vall d'Hebron) ; Bessonneau, Pascal (Paris-Diderot University) ; Thonon, Frédérique (Paris-Diderot University) ; Santos, Javier (Hospital Universitari Vall d'Hebron) ; Guagnozzi, Danila (Hospital Universitari Vall d'Hebron) ; Payakachat, Nalin (University of Arkansas for Medical Sciences) ; Coffin, Benoit (AP-HP) ; Azpiroz Vidaur, Fernando (Hospital Universitari Vall d'Hebron) ; Whorwell, Peter J. (University of Manchester) ; Chassany, Olivier (AP-HP) ; Universitat Autònoma de Barcelona
Gas-related symptoms (GRS) are common in the general population (GPop) and among patients with disorders of gut-brain interactions but there is no patient-reported outcome evaluating these symptoms and their impact on daily life. [...]
2021 - 10.1111/nmo.14202
Neurogastroenterology and Motility, Vol. 34 (june 2021)  
8.
3 p, 387.7 KB Patient-reported outcomes in NAFLD/NASH clinical trials : A blind spot that needs addressing / Sena, Elena (Hospital Universitari Vall d'Hebron) ; Manzano-Nunez, Ramiro (Hospital Universitari Vall d'Hebron) ; Rivera-Esteban, Jesús (Hospital Universitari Vall d'Hebron) ; Pericàs, Juan M (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
2022 - 10.1016/j.jhepr.2022.100597
JHEP Reports, Vol. 5 (september 2022)  
9.
21 p, 801.6 KB Patient-centered care in Coronary Heart Disease : what do you want to measure? A systematic review of reviews on patient-reported outcome measures / Pardo Cladellas, Yolanda (Institut Hospital del Mar d'Investigacions Mèdiques) ; Garin, Olatz (Institut Hospital del Mar d'Investigacions Mèdiques) ; Oriol, Cristina (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Zamora, Víctor (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ribera, A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferrer Forés, Maria Montserrat (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
The number of published articles on Patient-Reported Outcomes Measures (PROMs) in Coronary Heart Disease (CHD), a leading cause of disability-adjusted life years lost worldwide, has been growing in the last decades. [...]
2022 - 10.1007/s11136-022-03260-6
Quality of Life Research, Vol. 32 (november 2022) , p. 1405-1425  
10.
14 p, 2.0 MB Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer : patient-reported outcomes from the FLIPPER trial / Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Martínez, M. Teresa ; Ramos, Manuel ; de la Cruz Merino, Luis ; Santaballa, Ana ; O'Connor, Miriam ; Martínez-Jañez, Noelia ; Moreno, Fernando ; Fernández, Isaura ; Virizuela, Juan Antonio ; Alarcón, Jesús ; de la Haba Rodríguez, Juan Rafael ; Sánchez-Rovira, Pedro ; Albacar, Cinta Rosa ; Bueno Muiño, Coralia ; Kelly, Catherine ; Casas, Maribel ; Bezares, Susana ; Rosell, Libertad ; Albanell Mestres, Joan (Hospital del Mar (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona
In the FLIPPER trial, palbociclib/fulvestrant significantly improved progression-free survival (PFS) compared with placebo/fulvestrant in postmenopausal women with HR+/HER2− advanced breast cancer (ABC). [...]
2023 - 10.1177/17588359221148921
Therapeutic Advances in Medical Oncology, Vol. 15 (january 2023)  

Articles : 32 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.